-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
After the tumor tissue is destroyed by physical methods (such as photothermal therapy, radiation therapy, cryoablation, radiofrequency ablation, etc.
Tumor vaccines have become a hot field in the fight against cancer
In response to the above key issues in tumor vaccine research, Zhao Xiao's research team from the National Center for Nanoscience and Technology published a paper entitled: Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ in Wiley's flagship journal Small (IF=13.
Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy
The vaccine system can not only enhance the efficiency of antigen recognition and processing, but also realize the reactivation of the immunosuppressive microenvironment, enhance immune-mediated tumor clearance after photothermal therapy (PTT), and provide a new technology for the development of personalized tumor vaccines support
Vaccine design ideas and mechanism of action after PTT
Vaccine design ideas and mechanism of action after PTTGiven the time required for antigen release after photothermal therapy (PTT) ablation, the research team employed a two-step treatment strategy to improve synergistic immunotherapy after PTT
Overall, the OMV-based in situ vaccine with antigen capture and immunomodulatory functions developed in this study provides a promising strategy for the combination of topical therapy and immunotherapy
The OMV-based in situ vaccine with antigen capture and immunomodulatory functions developed in this study provides a promising strategy for the combination of topical therapy and immunotherapy
The National Nanoscience Center team has long been committed to using nanotechnology to design and develop different types of vaccine carriers
Original source:
Original source:Yao Li, Kaiyue Zhang, Yao Wu, et al.
Yao Li, Kaiyue Zhang, Yao Wu, et al.
Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy.
Small, 2022.
Leave a comment here